These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Value of meprobamate in dermatological therapy]. REBOUL E; REBOUL M; DORGEUILLE C Maroc Med; 1958 Jul; 37(398):784-800. PubMed ID: 13577055 [No Abstract] [Full Text] [Related]
5. [Meprobamate in the treatment of skin diseases]. FRIDERICH H Medizinische; 1958 Apr; 3(17):726-7. PubMed ID: 13551706 [No Abstract] [Full Text] [Related]
6. [Effects of administration of 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (meprobamate) in mental disorders]. IMBERCIADORI S; MANGANARO D Minerva Med; 1956 Dec; 47(102):2181-4. PubMed ID: 13399942 [No Abstract] [Full Text] [Related]
7. [Treatment of various dermatological diseases with prednisolone & meprobamate]. DEWEZ A Scalpel (Brux); 1958 Jul; 111(29):698-700. PubMed ID: 13580174 [No Abstract] [Full Text] [Related]
8. An evaluation of meprobamate in the management of selected dermatosis. BECKER FT; FREDRICKS MG; SCHMID JF; TUURA JL AMA Arch Derm; 1958 Apr; 77(4):406-9; discussion 409-11. PubMed ID: 13519839 [No Abstract] [Full Text] [Related]
9. Psychiatric use of a new tranquilizer: 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate). MACCAGNANI G Rass Neuropsichiatr; 1957; 11(3-4):145-71. PubMed ID: 13506106 [No Abstract] [Full Text] [Related]
10. [Personal experience with 2-methyl-2-propyl-1, 3-propanediol dicarbamate in a group of allergic patients]. GARAT B; BERRUEZO JJ; ORCIUELI L Dia Med; 1957 Mar; 29(10):234; passim. PubMed ID: 13427602 [No Abstract] [Full Text] [Related]
11. A clinical evaluation of miltown (2 methyl-2-N-propyl-1, 3 propanediol dicarbamate). WEINSTEIN GJ N Y State J Med; 1957 Jun; 57(12):2060. PubMed ID: 13441048 [No Abstract] [Full Text] [Related]
12. [Use of 2-methyl-2-N-propyl-1, 3-propanediol dicarbamate in psychiatry]. FLORIS V; RAMBELLI L Minerva Med; 1956 Nov; 47(88):1455-7. PubMed ID: 13387286 [No Abstract] [Full Text] [Related]
13. [Clinical use of a new drug with sedative action: 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate]. RIGOTTI S Minerva Med; 1956 Dec; 47(102):2178-81. PubMed ID: 13399941 [No Abstract] [Full Text] [Related]
19. Gas chromatographic determination of meprobamate, 2-methyl-2-propyl-1,3-propanediol dicarbamate, in plasma and urine. Douglas JF; Kelley TF; Smith NB; Stockage JA Anal Chem; 1967 Jul; 39(8):956-8. PubMed ID: 6042638 [No Abstract] [Full Text] [Related]